Skip to main content

Seres Therapeutics Inc

For the period ended Mar 13, 2025. Filed Mar 13, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Mar 13, 2025 · Filed Mar 13, 2025

MCRB$1.98-5.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Appendix C-2

Second paragraph of Article FOURTH section A. 2. of the Certificate of Incorporation:

“The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding)by the affirmative without a separate vote oftheany holders ofa majority of the stock of the Corporation entitled to vote shares of Common Stock, irrespective of the provisions of Section 242(b)(2) of the General Corporation Law of the State of Delaware.”

Third paragraph of Article FOURTH section B. of the Certificate of Incorporation:

“Subject to the rights of the holders of any series of Preferred Stock pursuant to the terms of this Certificate of Incorporation or any resolution or resolutions providing for the issuance of such series of stock adopted by the Board of Directors, the number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding)by the affirmative without a separate vote oftheany holders ofa majority of the stock of the Corporation entitled to vote shares of Preferred Stock, irrespective of the provisions of Section 242(b)(2) of the General Corporation Law of the State of Delaware.”

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.